While reporting financial results for the first quarter on Thursday, health care company Baxter International Inc. (BAX) initiated its earnings, adjusted earnings and sales growth guidance for the first quarter and raised its outlook for the full-year 2025.
For the second quarter, the company anticipates adjusted earnings from continuing operations in a range of $0.59 to $0.63 per share on sales growth from continuing operations of 4 to 5 percent on a reported basis and 1 to 2 percent on an operational basis.
On average, analysts polled expect the company to report earnings of $0.61 per share on a revenue decline of 25.67 percent to $2.83 billion for the quarter. Analysts' estimates typically exclude special items.
Looking ahead to fiscal 2025, the company now projects adjusted earnings from continuing operations in a range of $2.47 to $2.55 per share on sales growth from continuing operations of 7 to 8 percent on a reported basis, with 4 to 5 percent growth on an operational basis.
Previously, the company expected adjusted earnings from continuing operations in a range of $2.45 to $2.55 per share on sales growth from continuing operations of 5 to 6 percent on a reported basis, with 4 to 5 percent growth on an operational basis.
The Street is looking for earnings of 2.49 per share on revenue growth of 5.33 percent to $11.20 billion for the year.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.